Although the potential for immunomodulation has been recognized for many
years there has been an explosion of data in this field with relevance
especially to the treatment of chronic airway diseases. Most of the work
in this field has been conducted by Japanese investigators but in the
last decade there has been a body of work outside of Japan that supports
and enhances these findings. The book covers basic research like effects
on bacteria, anti-inflammatory and mucoregulatory effects, but also
clinical results with up-to-date information for the use of such
medications to potentially treat diseases as diverse as chronic airway
diseases, arthritis, inflammatory bowel disease, and cancer.
The volume is intended for pulmonary physicians, researchers in
inflammation research, and pharmaceutical companies interested in the
development of such agents. It provides background information for the
clinician as well as in depth exploration of cutting edge science.